Kintara Therapeutics has started a clinical trial to study REM-001, targeting patients with cutaneous metastatic breast cancer (CMBC).
This trial, which is open to...
A new multi-institutional study, led by a team of researchers including Prof Carlo Palmieri, Prof Hannah Linden, and others, investigated the effectiveness and safety...
Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment.
A...